Adrian Howd
Director of Finance/CFO presso BIVICTRIX THERAPEUTICS PLC
Provenienza dei contatti di primo grado di Adrian Howd
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Joh. Berenberg, Gossler & Co. KG (United Kingdom)
 Joh. Berenberg, Gossler & Co. KG (United Kingdom) Investment Banks/BrokersFinance Joh. Berenberg, Gossler & Co. KG (United Kingdom) (Berenberg-UK) is the Great Britain-based broker/dealer division of Joh. Berenberg, Gossler & Co. KG, a multinational full-service investment bank in Germany. Headquartered in London, Berenberg-UK was founded in 2003 and provides trading and brokerage services to institutional and corporate clients.
138
| Operating Division | Investment Banks/Brokers | 138 |
| Public Company | Biotechnology | 13 | |
| Public Company | Pharmaceuticals: Major | 9 | |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Blueberry Therapeutics Ltd.
 Blueberry Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Blueberry Therapeutics Ltd. engages in the development of innovative medicines. It offers nanomedicine, anti infection and anti microbial, anti inflammatory bowel diseases, acne, dermatitis and wound medicines. The company was founded by John Ridden and Mike Davies and is headquartered in Macclesfield, the United Kingdom.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Brandon Point Industries Ltd.
 Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Brandon Point Industries Ltd. operates as a life sciences company. It focuses on healthcare. The company was founded in 2014 by George Kelly Martin and John Oliver Thomas Given and is headquartered in Dublin, Ireland.
3
| Private Company | Medical/Nursing Services | 3 |
Wavebreak Therapeutics Ltd.
 Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Adrian Howd tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Nomura International Plc
 Nomura International Plc Investment Banks/BrokersFinance Nomura International Plc provides a variety of financial services including advisement, investment banking and asset management. It trades in and sells fixed income and equity products, including related derivatives; and provides investment banking services, and corporate finance and private equity services. The company is also involved in asset and principal finance business. It offers investment advisory and management, custody, and employment services. Nomura International was founded in 1981 and is headquartered in London, the United Kingdom. | Investment Banks/Brokers | Sales & Marketing Analyst-Equity | |
Citigroup Global Markets Ltd.
 Citigroup Global Markets Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Ltd. (CGML) is an international broker-dealer firm headquartered in London, UK. The firm was founded in 1983 and is a subsidiary of Citigroup Global Markets Holdings Bahamas Ltd., ultimately held by Citigroup, Inc. (NYSE: C) in the US. CGML has a major presence in the international financial markets as a dealer, market-maker and underwriter in equity and fixed income securities and offers risk-based solutions to producers and investors in commodity markets. They also provide corporate finance services to a wide range of corporate, institutional and government clients. Their trading activities encompass cash, exchange traded and OTC derivative markets. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| RADIUS HEALTH, INC. | Biotechnology | Chief Executive Officer Director/Board Member Chairman Director/Board Member | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Advanced Animal Diagnostics, Inc.
 Advanced Animal Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Advanced Animal Diagnostics, Inc. develops integrated systems and solutions for the detection of animal diseases. The firm engages in the researching, developing and commercializing on-farm diagnostic tests, such as QScout MLD for early detection of subclinical mastitis in dairy cows. It also provides solutions for the diagnosis and treatment of veterinary health problems including mastitis and other animal diseases. The company was founded by Rodolfo Rodriguez and Victor M. Minton in July 2001 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| NVN LIQUIDATION, INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member | |
Berenberg Capital Markets LLC
 Berenberg Capital Markets LLC Investment Banks/BrokersFinance Berenberg Capital Markets LLC (BCM) is a broker-dealer firm headquartered in New York City. The firm was founded in 2011 and is a subsidiary of Berenberg Americas LLC, ultimately held by Joh. Berenberg, Gossler & Co. KG in Germany. BCM provides equity execution services to institutional and corporate clients. | Investment Banks/Brokers | Chief Executive Officer Analyst-Equity | |
Innocrin Pharmaceuticals Holdings LLC
 Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Innocrin Pharmaceuticals Holdings LLC discovers and develops oral inhibitors for the treatment of Castration-Resistant Prostate Cancer (CRPC). The company is headquartered in Durham, NC. | Medical Specialties | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
JPMorgan Securities Plc
 JPMorgan Securities Plc Financial ConglomeratesFinance JPMorgan Securities Plc is a brokerage firm headquartered in London, UK. The firm was founded in 1992 and is a wholly-owned subsidiary of JP Morgan Capital Holdings Ltd., ultimately owned by JPMorgan Chase & Co. (NYSE: JPM) in the US. JPMorgan Securities provides market research, proprietary pricing data and analytics, and trade execution across multiple asset classes such as credit, equities and FX. They help institutional investors, traditional and alternative asset and fund managers, broker dealers and equity issuers meet the demands of changing markets. | Financial Conglomerates | Analyst-Equity Institutional Sales Analyst-Equity Analyst-Equity Analyst-Equity Institutional Sales Analyst-Equity Analyst-Equity Sales & Marketing | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree | |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Chief Executive Officer Corporate Officer/Principal | |
| University of Cambridge | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
Lonza Biologics Plc
 Lonza Biologics Plc Miscellaneous Commercial ServicesCommercial Services Lonza Biologics Plc manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies. The company was founded in 1897 and is headquartered in Slough, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer Director of Finance/CFO | |
Intersouth Partners
 Intersouth Partners Investment ManagersFinance Intersouth Partners (Intersouth Partners) is a venture capital firm founded in 1985 by Dennis Dougherty and Roy Rodwell. The firm is headquartered in Durham, North Carolina. | Investment Managers | Private Equity Investor Founder | |
Credit Suisse Securities (Europe) Ltd.
 Credit Suisse Securities (Europe) Ltd. Investment ManagersFinance Credit Suisse Securities (Europe) Ltd. (Credit Suisse Europe) is the Great Britain-based brokerage subsidiary of Credit Suisse Investment Holdings (UK), itself a subsidiary of Credit Suisse Group AG (SWX: CSGN) in Switzerland. The firm was founded in 1966 and formerly known as Credit Suisse First Boston (Europe) Ltd. Headquartered in London, Credit Suisse Europe arranges financing in international capital markets, provides financial advisory services and acts as a dealer in securities, derivatives and foreign exchange on a principal and agency basis for corporate and institutional investors. | Investment Managers | Analyst-Equity Analyst-Equity Analyst-Equity | |
| University College Dublin | College/University | Corporate Officer/Principal Undergraduate Degree | |
Morgan Stanley & Co. International Plc
 Morgan Stanley & Co. International Plc Regional BanksFinance Morgan Stanley & Co. International Plc (MSCI) is a brokerage firm headquartered in London, UK. The firm was founded in 1986 and is a subsidiary of Morgan Stanley Investments (UK), ultimately held by Morgan Stanley (NYSE: MS) in the US. MSCI provides a range of brokerage services to corporations, governments and financial institutions. | Regional Banks | Analyst-Equity Analyst-Equity Institutional Sales Analyst-Equity Analyst-Equity | |
Lurie Holdings, Inc.
 Lurie Holdings, Inc. Investment ManagersFinance Lurie Holdings Inc (Lurie Holdings) is a venture capital subsidiary of Ann & Robert H. Lurie Family Foundation founded in 1995. The firm is headquartered in Chicago, Illinois. | Investment Managers | President Chief Investment Officer | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
| University College London | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
HSBC Bank Plc (Broker)
 HSBC Bank Plc (Broker) Investment Banks/BrokersFinance HSBC Bank Plc (Broker) (HSBC Bank-Broker) is the broker/dealer division of HSBC Bank Plc, which is owned by HSBC Holdings Plc (LON: HSBA; NYSE: HSBC) in Great Britain. Headquartered in London, HSBC Bank-Broker was founded in 1880 and offers bespoke brokerage services across every major asset class for their corporate and institutional clients. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Hatteras Venture Partners
 Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Investment Managers | Private Equity Investor Private Equity Investor | |
Joh. Berenberg, Gossler & Co. KG
 Joh. Berenberg, Gossler & Co. KG Investment ManagersFinance Joh. Berenberg, Gossler & Co. KG (dba Berenberg Bank) is an independent broker/dealer firm headquartered in Hamburg, Germany. Berenberg Bank provides brokerage services for a range of clients. | Investment Managers | Analyst-Equity Analyst-Equity Analyst-Equity Economist | |
MF Global UK Ltd.
 MF Global UK Ltd. Investment Banks/BrokersFinance Part of MF Global Holdings Ltd., MF Global UK Ltd. is a private company that provides brokerage services. The company is based in London, UK. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity Sales & Marketing | |
Redburn (Europe) Ltd.
 Redburn (Europe) Ltd. Investment Banks/BrokersFinance Redburn (Europe) Ltd. is an independent equity brokerage firm headquartered in London, UK. The firm was founded in 2003 by Jeremy Evans and Nick Glydon. They provide institutional investors with equity research, quantitative and technical analysis, economics research and agency execution in European and North American equity markets and serve corporates via their Equity Capital Markets division. Redburn’s Execution Services deliver high-touch sales trading and execution and low-touch execution and algorithmic solutions. Their Equity Capital Markets team originates, structures and executes equity and equity-linked transactions. | Investment Banks/Brokers | Sales & Marketing Analyst-Equity | |
| NatWest Markets Plc (Broker) | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Stephen M. Ross School of Business | College/University | Masters Business Admin Masters Business Admin | |
Novartis Venture Funds (USA)
 Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | Investment Managers | Private Equity Investor Private Equity Investor | |
Jefferies International Ltd.
 Jefferies International Ltd. Investment Banks/BrokersFinance Jefferies International Ltd. (JIL) is a brokerage firm headquartered in London, UK. The firm was founded in 1986 and is a subsidiary of Jefferies Holdings II Ltd., ultimately held by Jefferies Financial Group, Inc. (NYSE: JEF) in the US. JIL provides broking services to various investors. | Investment Banks/Brokers | Sales & Marketing Analyst-Equity | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
Altan Pharma Ltd.
 Altan Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Ethypharm SAS, Altan Pharma Ltd. is an Irish company that develops, manufactures, and markets injectable medications. The private company is based in Dublin, Ireland. The company was founded in 1998 by Guillermo A. Herrera. Guillermo A. Herrera has been the CEO since 1998. Altan Pharma was acquired by Ethypharm SAS from Malin Corp. Plc on October 01, 2021. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Malin Life Sciences Holdings Ltd.
 Malin Life Sciences Holdings Ltd. Financial ConglomeratesFinance Part of Malin Corp. Plc, Malin Life Sciences Holdings Ltd. functions as an investment holding Irish company. The private company is based in Dublin, Ireland. The CEO of the company is George Kelly Martin. | Financial Conglomerates | Chief Executive Officer Director/Board Member Director/Board Member | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member Director/Board Member | |
| TRISALUS LIFE SCIENCES, INC. | Medical Specialties | Director/Board Member Director of Finance/CFO Director/Board Member | |
Serenus Biotherapeutics, Inc.
 Serenus Biotherapeutics, Inc. Medical DistributorsDistribution Services Serenus Biotherapeutics, Inc. distributes and manufactures pharmaceutical drug products. The company is headquartered in San Francisco, CA. | Medical Distributors | Chairman Director/Board Member | |
Innocrin Pharmaceuticals, Inc.
 Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Regno Unito | 24 |
| Stati Uniti | 22 |
| Irlanda | 5 |
| Svizzera | 2 |
| Germania | 2 |
Settori
| Finance | 24 |
| Health Technology | 18 |
| Consumer Services | 7 |
| Commercial Services | 3 |
| Government | 2 |
Posizioni
| Director/Board Member | 314 |
| Analyst-Equity | 122 |
| Independent Dir/Board Member | 86 |
| Corporate Officer/Principal | 84 |
| Chairman | 73 |
Contatti più connessi
| Insiders | |
|---|---|
| Robert Alexander Ingram | 43 |
| Iain Ross | 41 |
| Andrew von Eschenbach | 32 |
| Douglas Reed | 27 |
| Michael Kauffman | 24 |
| Owen Hughes | 23 |
| Steve D. Weinstein | 23 |
| Dennis Dougherty | 23 |
| Sean Murphy | 22 |
| S. Torres | 21 |
| Jean-Michel Cossery | 21 |
| George Martin | 20 |
| Huai Zheng Peng | 19 |
| Kristopher Wood | 19 |
| Michal Silverberg | 17 |
- Borsa valori
- Insiders
- Adrian Howd
- Connessioni Società
